Sanara MedTech Inc. (SMTI) Misses Q3 EPS by 13c

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q3 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $16 million versus the consensus estimate of $18.8 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15